Alain Beck

Senior Director - Biologics Chemisty Manufacturing Controls & Developability

Pierre Fabre

Ali Chesney

Director of Toxicology

ImmunoGen

Andrea Ruggiero

Director - GRA CMC Regulatory Intelligence

Merck KGaA, Healthcare

Anikó Pálfi

Director Biochemistry & Cell Biology

Heideburg Pharma

Astrid Clarke

Director, IND to Medicine Research

Seagen

Benedicte Recolin

Associate Director - Safety Sciences

AstraZeneca

Benjamin Fabre

Scientist Expert In Conjugation Development

Sanofi

Benjamin Thomas

Senior Vice President - External Innovation and Operations

Oxford Biotherapeutics

Bertrand Cottineau

Head of R&D

Axplora

Bob Lutz

Chief Scientific Officer

Iksuda Therapeutics

Brandon Coyle

Senior Research Scientist II Purification

Gilead

Christina Derleth

Vice President - Clinical Development

Seagen

Christine Koehler

Head, Antibody Engineering

VERAXA Biotech

Colin McKee

Head of Technical Services

Sterling Pharma Solutions

Colm Readdington

Director - Global Regulatory, Chemistry, Manufacturing & Control

AstraZeneca

Conor Barry

Head of Development

Piramal Pharma Solutions

Daniel Milano

Senior Director, Process Development

ImmunoGen

Dhiraj Gambhire

Executive Director - Global Clinical Lead, Enhertu, Breast & Medical

Daiichi Sankyo

Douglas Levine

Senior Principal Scientist, Early Oncology Development

MSD

Emmett Schmidtt

Vice President, Lead External Collaborations Project Team, Global Clinical Development

MSD

Eshita Khera

Principal Scientist II

Novartis

Futa Mimoto

Senior Director - Protein Analysis, Pharmacokinetics & Oncology Pharmacology Unit Research Manager

Chugai Pharmaceuticals

Gerold Meindhardt

Vice President, Asset & Portfolio Management

Daiichi Sankyo

Gilles Gallant

Chief Development Officer

Mythic Therapeutics

Giorgio Salciarini

Marketing & Business Development Manager

BSP Pharmaceuticals

Greg Adams

Chief Scientific Officer

Elucida Oncology

Hans-George Lerchen

Chief Scientific Officer

Vincerx

Haowei Song

Principal Scientist in Novel Modalities R&D

Merck KGaA

Hongmei Xu

Vice President, Head of Quantitative Pharmacology Clinical Development

Bicycle Therapeutics

Ian Andrews

Senior Manager, Strategic External Development

GlaxoSmithKline

Jacqueline Leuci

Development Associate II

ImmunoGen

Jahan Khalili

Vice President, Immuno-Oncology

Systimmune

Jake Morris

Account Manager

Beacon

Jake Spies

Senior Scientist Group Lead Process & Analytical Development

MERCK

Jamie Baker

Professor

University College London

Jan Schnitzer

Founder, Director & Chief Executive Officer

PRISM

Jesus Fuentas Antras

Clinical Research Fellow

Princess Margaret Cancer Centre

Jia He

Researcher

Beacon

Jian Chen

Director - Translational Research & Preclinical Development

BioAtla

Jianwen Feng

Senior Director, Antibody Discovery & Protien Science

Pyxis Oncology

Jimmy Li

Chief Executive Officer

WuXi Biologics

JinChen Yu

Senior Vice President

Bio-Thera Solutions

Jiong Yang

Director, Quality

MSD

Joanne McGregor

Director, Head ADC Platform

GlaxoSmithKline

John Lambert

Independent Consultant

John Zhu

Chief Executive Officer

Duality Bio

José M. Mejía Oneto

Chief Executive Officer

Shasqi

Juan Carlos Cordova

Associate Director, Bioconjugation Process Development & Manufacturing

LOXO Oncology

Julie Beaudet

CMC Staff Scientist

Regeneron Pharmaceuticals

Jutta Deckert

Executive Director - Translational R&D

Iksuda Therapeutics

Kerry Chester

Professor of Molecular Medicine Research Department of Oncology

University College London

Krista Kinneer

Director, Translational Medicine

AstraZeneca

Kurt Pike

Senior Director, External Innovation

The Janssen Pharmaceutical Companies of Johnson & Johnson

Larisa Stone

Clinical Development Director

Gilead

Leó Marx

Medicinal Chemist & Bioconjugation Manager

Debiopharm

Lolke De Haan

Vice President - Toxicology

ADC Therapeutics

Martha Neagu

Medical Director, Oncology Early Development

AbbVie

Martina Antonelli

Researcher

Merck KGaA

Michael Alonso

Marketing & Business Development Manager

BSP Pharmaceuticals

Michael Method

Executive Medical Director

Immunogen

Michael Seganish

Senior Principal Scientist, Discovery Chemistry

Merck KGaA

Mike Liao

Global Clinical Pharmacology Lead

Genentech

Ming-Tian Lai

Chief Scientific Officer

OBI Pharma

Mohit Rawat

President & Chief Business Officer

Fusion Pharmaceuticals

Nathan Alves

Associate Professor / Director of Translational Research

Indiana University School of Medicine

Nicolas Camper

Senior Director, Bioconjugation Chemistry

Abzena

Nienke Vriezen

Senior Director Upstream

Byondis

Noah Bindman

Principal Scientist

Seagen

Oliver Ducoudret

Senior Development Specialist (Quality Control)

MacroGenics

Paul Song

Chief Scientific Officer

Genequantum Healthcare

Rachel Shi

Chief Medical Officer

Genequantum Healthcare

Raffaele Colombo

Principal Scientist & Group Lead, Medicinal Chemisty

Zymeworks

Rakesh Dixit

Independent Consultant

See Phan

Vice President, Clinical Research Oncology

Gilead

Shuwen Sun

Principal Scientist

Merck & Co.

Stepan Chuprakov

Director, Chemistry

Catalent Biologics

Stephanie Monson

Principal Scientist

Genentech

Sunny-Zhou

Professor

Northeastern University School of Science

Thomas Nittoli

Director - R&D Chemistry Therapeutic Proteins

Regeneron Pharmaceuticals

Thomas Powles

Director

Barts Cancer Institute

Tomohiro Fujii

ADC Researcher

Ajinomoto Bio-Pharma Services

Torbjorn Graslund

Associate Professor

KTH Royal Institute of Technology

Venkatesh Pilla Reddy

Senior Director, Global PKPD & Pharmacometrics

Eli Lilly

Vijay Chudasama

Professor

University College London

Vincent Blot

Senior Director - Oncology Clinical Development

AbbVie

W. Frank An

Senior Director of Antibody Therapeutics

Biocytogen

William Goundry

Principal Scientist - New Modalities

AstraZeneca

Yan Shi

Chief Medical Officer

Genequantum Healthcare

Yang Qiu

Chief Scientific Officer

Duality Biologics

Yariv Hefez

Senior Vice President Head Global Business Franchise Oncology

Merck Group

Zaiqi Wang

Chairman & Chief Executive Officer

Inxmed